MEMPHIS, Tenn., Sept. 22 /PRNewswire/ -- Accelerated Community Oncology Research Network (ACORN) (TM), a national oncology-focused Contract Research Organization (CRO) and clinical trial network, announced today that it has named Tara Webb as Senior Director of Business Development. Webb brings a successful record of establishing and cultivating CRO relationships. "Tara Webb has an exceptional background of work in the CRO field and is widely respected for her industry knowledge, capabilities and integrity," remarked Edward J. Stepanski, PhD, Chief Operations Officer of ACORN. "Her responsibilities at ACORN CRO will include presenting ACORN's capabilities to pharmaceutical companies and emerging biotechs, forging alliances with key accounts and providing customer service oversight on behalf of clients." Most recently, Webb served as Senior Director, Business Development for i3 Statprobe, where she was responsible for developing new business opportunities and strengthening current client relationships both nationally and internationally.
ACORN CRO will provide Webb with the platform to focus her energies exclusively in the field of oncology, thus enabling closer working relationships with a select group of sponsors. "Tara Webb is an excellent fit with our organization as she is known for her dedication and determination to consistently provide her clients and their projects with uncompromising standards of quality," stated Steve Coplon, ACORN CEO. "With a decade of research experience augmented by a strong, technological background, she will provide excellent representation of ACORN CRO's scientific strength, unprecedented community oncology relationships, and ACORN's proprietary technology, including Guardian EDC(TM)," added Coplon.
Webb holds a M.S. in Organizational Leadership & Administration and a B.S. in Health Administration (Accelerated Program) from Concordia College, Ann Arbor, Michigan.
About ACORN CRO
ACORN CRO provides a full range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. Exclusively focused on oncology, ACORN CRO is backed by scientists and medical professionals dedicated to advancing cancer care through research. An important added strength resides in ACORN's network of community oncology researchers, specifically selected for their commitment to oncology research and excellence in its execution. ACORN, Inc., a privately held company, significantly enhances the speed, accuracy, and productivity of conducting clinical research in the community oncology setting. Proactive project management with focused teams of clinical experts achieves these goals. Well-defined processes augmented by proprietary technology provide oversight and efficiencies on study functions for both pharma and participating sites.
Webb can be reached at email@example.com or (901) 435-5570.
For additional information, contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878 or visit http://www.ACORNresearch.net .
Accelerated Community Oncology Research Network, Inc. (TM) (ACORN)
ACORN focuses on oncology exclusively. ACORN offers centralized clinical
trial services, scientific analysis, and is a full-service Contract
Research Organization (CRO), providing contract and budgeting services;
fostering accrual of subjects at the site level; collecting data and
monitoring its accuracy; and working seamlessly with both trial sponsors
and participating practices.
Deborah D. Coble
|SOURCE Accelerated Community Oncology Research Network|
Copyright©2008 PR Newswire.
All rights reserved